WO2025224609 - POTENCY ASSAY
National phase entry is expected:
Publication Number
WO/2025/224609
Publication Date
30.10.2025
International Application No.
PCT/IB2025/054171
International Filing Date
22.04.2025
Title **
[English]
POTENCY ASSAY
[French]
DOSAGE DE POTENTIEL
Applicants **
SEQIRUS INC.
Inventors
QIAN, Jiang
MA, Wenchuan
FOX, Marissa
Priority Data
63/637,419
23.04.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
USPTO
* |
| * | |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3783 | |
| EPO | Filing, Examination, Granting | 30796 | |
| Japan | Filing, Examination, Granting | 3140 | |
| South Korea | Filing, Examination, Granting | 4251 | |
| USA | Filing, Examination, Granting | 11960 |
Total:
53,930
Contact Us
Abstract[English]
The present disclosure provides a method for quantifying a target protein in a sample making use of differentially isotopically labeled variants of the target protein.[French]
La présente divulgation concerne un procédé de quantification d'une protéine cible dans un échantillon faisant appel à des variants de la protéine cible marqués de manière isotopique différentielle.